Procter & Gamble Meet Earnings Estimates in Q3, Organic Sales Up 1% Y/Y

Core Insights - Procter & Gamble reported mixed results for Q3 fiscal 2025, with earnings meeting estimates but sales falling short [1][2] - Organic sales increased year over year due to higher pricing, despite a decline in overall sales [1][3] Financial Performance - Core earnings per share (EPS) were $1.54, a 1% increase from the previous year, matching the Zacks Consensus Estimate [1] - Net sales totaled $19.8 billion, down 2% year over year, missing the expected $20.3 billion [2] - Organic sales rose 1% year over year, driven by pricing, while volumes dropped by 1% [2][3] Segment Performance - The Baby, Feminine & Family Care segment saw a 4% decline, while Fabric & Home Care dropped by 3% [4] - Grooming and Beauty segments experienced a 1% organic sales increase, but Health Care and Fabric & Home Care remained flat [4] Margin Analysis - Core gross margin decreased by 30 basis points to 51%, with adverse currency impacts contributing to the decline [6] - Core operating margin expanded by 90 basis points to 23%, aided by gross productivity savings [8] Cash Flow and Shareholder Returns - The company ended the quarter with cash and cash equivalents of $9.1 billion and generated an operating cash flow of $3.7 billion [9] - Procter & Gamble returned $3.8 billion to shareholders, including $2.4 billion in dividends and $1.4 billion in share buybacks [10] Guidance Adjustments - The company lowered its fiscal 2025 sales and EPS guidance due to market conditions, now expecting organic sales growth of 2% [11][12] - Projected core EPS growth is now between $6.72 and $6.82, reflecting a decrease from previous estimates [13] Cost Headwinds - Procter & Gamble anticipates commodity cost headwinds of approximately $200 million after tax, along with adverse foreign exchange impacts [14] - The company expects a total headwind of 16 cents per share due to these factors [14]